New CVS and Express Scripts Value Based Plans for Oncology

CVS and Express Scripts recently announced new plans to determine price and access to cancer drugs based on value. Learn more about these plans and others, such as Memorial Sloan Kettering’s Drug Abacus here. (Source: Tracey Walker, 4/3/16)

You might also be interested in:

PAI and BresMed Join Forces to Support Expanded Use of More… July 22, 2019
Biomarkers and Companion diagnostics: Payer Insights September 26, 2019
Pharmerit Expands Market Access Support in Asia January 17, 2019
The Global Use of Medicine in 2019 and Outlook to 2023 January 29, 2019
The Growing Influence of the Institute of Clinical and… November 21, 2019
Leveraging Technology to Reduce Costs in Clinical Trials June 30, 2019
The Future of Key Account Management in Pharma September 26, 2019